These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3779622)

  • 1. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry.
    Badalament RA; Gay H; Whitmore WF; Herr HW; Fair WR; Oettgen HF; Melamed MR
    Cancer; 1986 Dec; 58(12):2751-7. PubMed ID: 3779622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
    Badalament RA; Gay H; Cibas ES; Herr HW; Whitmore WF; Fair WR; Melamed MR
    J Urol; 1987 Oct; 138(4):763-5. PubMed ID: 3656528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry as a predictor of response and progression in patients with superficial bladder cancer treated with bacillus Calmette-Guerin.
    Bretton PR; Herr HW; Kimmel M; Fair WR; Whitmore WF; Melamed MR
    J Urol; 1989 Jun; 141(6):1332-6. PubMed ID: 2724430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.
    Schwalb MD; Herr HW; Sogani PC; Russo P; Sheinfeld J; Fair WR
    J Urol; 1994 Aug; 152(2 Pt 1):382-7. PubMed ID: 8015076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry of low stage bladder tumors: correlation with cytologic and cystoscopic diagnosis.
    Devonec M; Darzynkiewicz Z; Kostyrka-Claps ML; Collste L; Whitmore WF; Melamed MR
    Cancer; 1982 Jan; 49(1):109-18. PubMed ID: 6172190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Feb; 16(2):192-5. PubMed ID: 19054166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
    Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
    Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer.
    Hermans J; Jokisch F; Volz Y; Eismann L; Pfitzinger P; Ebner B; Weinhold P; Schlenker B; Stief CG; Tritschler S; Schulz GB
    Cancer Cytopathol; 2022 Apr; 130(4):294-302. PubMed ID: 34919338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine transurethral biopsy of the bladder is not necessary to evaluate the response to bacillus calmette-guerin therapy.
    Murakami T; Ebara S; Saika T; Irie S; Takeda K; Maki Y; Miyaji S; Manabe D; Kaku H; Nasu Y; Tsushima T; Kumon H
    Acta Med Okayama; 2007 Dec; 61(6):341-4. PubMed ID: 18183079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometry.
    Staiano-Coico L; Huffman J; Wolf R; Pinsky CM; Herr HW; Whitmore WF; Oettgen HF; Darzynkiewicz Z; Melamed MR
    J Urol; 1985 May; 133(5):786-8. PubMed ID: 3989917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
    Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
    Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?
    Guy L; Savareux L; Molinié V; Botto H; Boiteux JP; Lebret T
    Eur Urol; 2006 Sep; 50(3):516-20; discussion 520. PubMed ID: 16632184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
    Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
    Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of flow cytometric DNA analysis in bladder cancer--comparison with conventional cytology].
    Kawasaki T
    Hinyokika Kiyo; 1991 Nov; 37(11):1481-9. PubMed ID: 1767770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.
    Taylor JH; Davis J; Schellhammer P
    Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy.
    Savic S; Zlobec I; Thalmann GN; Engeler D; Schmauss M; Lehmann K; Mattarelli G; Eichenberger T; Dalquen P; Spieler P; Schoenegg R; Gasser TC; Sulser T; Forster T; Zellweger T; Casella R; Bubendorf L
    Int J Cancer; 2009 Jun; 124(12):2899-904. PubMed ID: 19230026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Value of Combined Urine Cytology and Cystoscopy for Follow-up of Superficial Transitional Cell Carcinoma of the Urinary Bladder.
    Tahoun NS; Abdel Maksoud AM; Mohamed DB
    J Egypt Natl Canc Inst; 2010 Jun; 22(2):105-11. PubMed ID: 21860467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
    de Reijke TM; de Boer EC; Kurth KH; Schamhart DH
    J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
    Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
    Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience.
    Klein FA; White FK
    J Urol; 1988 Feb; 139(2):275-8. PubMed ID: 3339724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.